Approvals/TGA/SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe

Approved

STANDARD

SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe

Moderna Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 555d7347ce9dda1a
Product Name: SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
Artg Id: 458805
Artg Name: SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
Sponsor: Moderna Australia Pty Ltd
Company Detail Path: /organization/moderna-australia-pty-ltd
Artg Date: 2024-11-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a74da921e80fbb55253284d9e9ee38e1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e2a5ef204aeb60cb44e973021d541bf5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

555d7347ce9dda1a

Type

Standard